Ignite Creation Date:
2025-12-25 @ 1:22 AM
Ignite Modification Date:
2026-01-27 @ 12:22 AM
Study NCT ID:
NCT03155893
Status:
COMPLETED
Last Update Posted:
2017-11-14
First Post:
2017-05-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Cardiac Safety of a Single Dose of AL-335 Administered on a Background of Simeprevir and Odalasvir and of Repeated Doses of Odalasvir Administered Alone in Healthy Participants
Sponsor:
Janssen Research & Development, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-05-12
Start Date Type:
ACTUAL
Primary Completion Date:
2017-10-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-10-27
Completion Date Type:
ACTUAL
First Submit Date:
2017-05-15
First Submit QC Date:
None
Study First Post Date:
2017-05-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-11-10
Last Update Post Date:
2017-11-14
Last Update Post Date Type:
ACTUAL